Ftse Mib
33.577,42
-0,39%
DAX
18.155,24
-0,04%
S&P 500
5.475,52
0,11%
NASDAQ
17.774,84
0,32%
Bitcoin
61.498,44
-0,51%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Serologicals (MM) (SERO) Serologicals (MM) (SERO) Notizie

SERO

Serologicals (SERO)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SERO
DataOraFonteTitoloSimboloCompagnia
12/07/200617:21Business WireSerologicals Announces Stockholder Approval of MergerNASDAQ:SEROSerologicals (MM)
06/07/200615:00Business WireCelliance Enters Agreement with Novozymes A/S to Develop Animal-Free Recombinant Human AlbuminNASDAQ:SEROSerologicals (MM)
21/06/200617:01Business WireSerologicals' Upstate Group Announces Winner of 2006 Young Cell Signaller Award; Rashu Bhargava Seth Receives Award at the ThirNASDAQ:SEROSerologicals (MM)
17/05/200614:00Business WireSerologicals' Upstate Group Announces Five Finalists for the 2006 Young Cell Signaller Award; Winner to be chosen June 13, 2006NASDAQ:SEROSerologicals (MM)
02/05/200621:02Business WireSerologicals Corporation Announces Completion of Acquisition of LINCONASDAQ:SEROSerologicals (MM)
26/04/200612:00Business WireSerologicals Corporation Reports First Quarter Results; First Quarter Revenue Exceeds Expectations and Pro Forma Net Income upNASDAQ:SEROSerologicals (MM)
21/04/200616:18Business WireChemicon International and Australian Stem Cell Centre Announce Exclusive Agreement to Commercialize Stem Cell ProductsNASDAQ:SEROSerologicals (MM)
17/04/200615:00Business WireSerologicals Corporation Schedules First Quarter Earnings Release and Conference CallNASDAQ:SEROSerologicals (MM)
12/04/200615:00PR Newswire (US)Stem Cell Signaling Measured for the 1st TimeNASDAQ:SEROSerologicals (MM)
31/03/200617:23Business WireSerologicals Corporation Announces Completion of Acquisition of Cytomyx Ltd.NASDAQ:SEROSerologicals (MM)
24/03/200600:34Business WireSerologicals Corporation Agrees to Acquire LINCO; Solidifies Serologicals as a Leader in Multiplexing MarketplaceNASDAQ:SEROSerologicals (MM)
16/03/200615:00Business WireSerologicals Corporation Announces Expanded Multi-Year Distribution Agreement with Novo Nordisk; Celliance is Exclusive DistribNASDAQ:SEROSerologicals (MM)
14/03/200615:00Business WireSerologicals Corporation Agrees to Acquire Cytomyx Ltd.; Expands Drug Discovery Screening PortfolioNASDAQ:SEROSerologicals (MM)
28/02/200616:00Business WireChemicon International and Stem Cell Sciences Announce Launch of ESGRO Complete(TM) Product LineNASDAQ:SEROSerologicals (MM)
22/02/200622:05Business WireSerologicals Corporation Reports Fourth Quarter and Full Year 2005 Results; Fourth Quarter Revenue up 26.0% and Pro Forma Net InNASDAQ:SEROSerologicals (MM)
08/02/200615:15Business WireSerologicals Corporation Schedules Fourth Quarter Earnings Release and Conference CallNASDAQ:SEROSerologicals (MM)
07/02/200618:06Business WireChemicon International and Cellumen Announce an R & D Agreement to Commercialize a Systems Cell Biology Approach to CytotoxicityNASDAQ:SEROSerologicals (MM)
17/01/200615:35PR Newswire (US)SeraCare Closes Previously Announced Purchase of Celliance Milford AssetsNASDAQ:SEROSerologicals (MM)
10/01/200616:30Business WireChemicon International and MorphoSys Enter into Worldwide Licensing Agreement for Research AntibodiesNASDAQ:SEROSerologicals (MM)
06/01/200617:14Business WireSerologicals Corporation Announces Plant Rationalization ActionsNASDAQ:SEROSerologicals (MM)
03/01/200616:00Business WireSerologicals Corporation to Present at 24th Annual JPMorgan Healthcare ConferenceNASDAQ:SEROSerologicals (MM)
29/11/200513:00PR Newswire (US)SeraCare Announces Acquisition of Serologicals' Celliance Subsidiary AssetsNASDAQ:SEROSerologicals (MM)
14/11/200520:30Business WireSerologicals Corporation President & CEO David A. Dodd to Speak at J. Mack Robinson College of Business at Georgia State UniversNASDAQ:SEROSerologicals (MM)
10/11/200515:14Business WireSerologicals Corporation to Present at 2005 First Analysis Investment ConferenceNASDAQ:SEROSerologicals (MM)
08/11/200517:45Business WireStem Cell Experts Engage at 2nd Annual Christopher Reeve Hot Topics in Stem Cell Biology Satellite SymposiumNASDAQ:SEROSerologicals (MM)
27/10/200522:01Business WireSerologicals Corporation Reports Third Quarter Results; Revenues Increase 45% for the Quarter and 48% for First Nine MonthsNASDAQ:SEROSerologicals (MM)
26/10/200515:00Business WireSerologicals Corporation to Present at JPMorgan Small Cap ConferenceNASDAQ:SEROSerologicals (MM)
17/10/200520:46Business WireSerologicals Corporation Third Quarter 2005 Earnings Conference CallNASDAQ:SEROSerologicals (MM)
13/10/200516:00Business WireSerologicals Corporation Announces UCOE PatentNASDAQ:SEROSerologicals (MM)
06/10/200512:00Business WireChemicon Announces Agreement with Stem Cell Sciences for Exclusive Manufacturing and Marketing of Novel, Serum-free, Embryonic SNASDAQ:SEROSerologicals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SERO

La tua Cronologia

BIT
P12X29
BNP PARIBAS ISSUANCE
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network